布鲁克公司收购 Spectral Instruments Imaging 和 Nanophoton，扩大其临床前解决方案和分子显微镜产品组合。 Bruker Corporation acquires Spectral Instruments Imaging and Nanophoton, expanding its preclinical solutions and molecular microscopy portfolio.
布鲁克公司最近宣布收购 Spectral Instruments Imaging (SII)，一家领先的临床前体内光学成像系统公司。 Bruker Corporation has recently announced the acquisition of Spectral Instruments Imaging (SII), a leading preclinical in-vivo optical imaging systems company. 此次收购以及后来对 Nanophoton Corporation 的收购，扩大了布鲁克用于疾病研究的临床前解决方案的范围，并扩展了其分子显微镜产品组合。 This acquisition, along with the later acquisition of Nanophoton Corporation, broadens Bruker's range of preclinical solutions for disease research and expands its molecular microscopy portfolio. SII 以其先进的光学和技术而闻名，而 Nanophoton 是日本拉曼显微镜研究领域的先驱公司。 SII is known for its advanced optics and technology while Nanophoton is a pioneering Japanese company in research Raman microscopy. 两家公司都提供临床前研究、半导体检查、电池测试等应用的技术。 Both companies provide technologies for applications in preclinical research, semiconductor inspection, battery testing, and more.